Request SampleGlobal Plasma Fractionation Sales Market Report 2023
SKU ID : QYR-22285847 | Publishing Date : 02-Jan-2023 | No. of pages : 133
Market Analysis and Insights: Global Plasma Fractionation Market
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Due to the COVID-19 pandemic, the global Plasma Fractionation market size is estimated to be worth US$ 28100 million in 2022 and is forecast to a readjusted size of US$ 47210 million by 2029 with a CAGR of 7.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Albumin accounting for % of the Plasma Fractionation global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Immunology segment is altered to an % CAGR throughout this forecast period.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
Global Plasma Fractionation Scope and Market Size
The global Plasma Fractionation market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Albumin
Immune Globulin
Coagulation Factor
Others
Segment by Application
Immunology
Hematology
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Due to the COVID-19 pandemic, the global Plasma Fractionation market size is estimated to be worth US$ 28100 million in 2022 and is forecast to a readjusted size of US$ 47210 million by 2029 with a CAGR of 7.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Albumin accounting for % of the Plasma Fractionation global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Immunology segment is altered to an % CAGR throughout this forecast period.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
Global Plasma Fractionation Scope and Market Size
The global Plasma Fractionation market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Plasma Fractionation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Albumin
Immune Globulin
Coagulation Factor
Others
Segment by Application
Immunology
Hematology
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
24/7 Research Support
Phone: +1 (888) 690-5999 
